Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Huang, Stephen S H ^a,b   Banner, David ^a   Fang, Yuan ^a,b   Ng, Derek C K ^a   Kanagasabai, Thirumagal ^a   Kelvin, David J ^a,b,c,d,e   Kelvin, Alyson A ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Immune Diagnostics and Research   (Canada)

^d SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^e UNIVERSITY OF SASSARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FERRET; HISTOPATHOLOGY; IMMOBILIZATION; IMMUNOPATHOLOGY; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS B; MALE; NONHUMAN; NOSE SECRETION; PANDEMIC INFLUENZA; SCORING SYSTEM; SEASONAL INFLUENZA; SNEEZING; STRAIN DIFFERENCE; UPPER RESPIRATORY TRACT; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; ANTIBODY SPECIFICITY; HUMAN; IMMUNOLOGY; LUNG; ORTHOMYXOVIRUS INFECTION; PANDEMIC; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RESPIRATORY TRACT INFECTION; SEASON; SPECIES DIFFERENCE; TIME; VIROLOGY;

ANIMALIA; CERCOPITHECINE HERPESVIRUS 1; MUSTELA; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BODY TEMPERATURE; BODY WEIGHT; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; LUNG; MALE; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; RESPIRATORY TRACT INFECTIONS; SEASONS; SNEEZING; SPECIES SPECIFICITY; TIME FACTORS; VIRUS REPLICATION;

EID: 81155128253     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027512     Document Type: Article

References (40)

1. Munster VJ, Fouchier RA, (2009) Avian influenza virus: of virus and bird ecology. Vaccine 27: 6340-6344.
2. Sym D, Patel PN, El Chaar GM, (2009) Seasonal, avian, and novel H1N1 influenza: prevention and treatment modalities. Ann Pharmacother 43: 2001-2011.
3. Girard MP, Tam JS, Assossou OM, Kieny MP, (2010) The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine 28: 4895-4902.
4. Khanna M, Kumar P, Choudhary K, Kumar B, Vijayan VK, (2008) Emerging influenza virus: a global threat. J Biosci 33: 475-482.
5. Rajagopal S, Treanor J, (2007) Pandemic (avian) influenza. Semin Respir Crit Care Med 28: 159-170.
6. Influenza (Seasonal). World Health Organization (WHO). Available: http://www.who.int/mediacentre/factsheets/fs211/en/index.html. Accessed 2011 Oct 19.
7. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, et al. (2003) Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 289: 179-186.
8. Fouchier RA, Munster V, Wallensten A, Bestebroer TM, Herfst S, et al. (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79: 2814-2822.
9. Hay AJ, Gregory V, Douglas AR, Lin YP, (2001) The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356: 1861-1870.
10. Holmes EC, (2009) RNA virus genomics: a world of possibilities. J Clin Invest 119: 2488-2495.
11. Capua I, Alexander DJ, (2002) Avian influenza and human health. Acta Trop 83: 1-6.
12. Palese P, (2004) Influenza: old and new threats. Nat Med 10: S82-S87.
13. World Health Organization (WHO) (2009) Characteristics of the emergent influenza A (H1N1) viruses andrecommendations for vaccine development. Avaliable: http://www.who.int/csr/resources/publications/swineflu/H1N1Vaccinevirusrecommendation26May2009.pdf. Accessed 2011 Oct 19.
14. Nobusawa E, Sato K, (2006) Comparison of the mutation rates of human influenza A and B viruses. J Virol 80: 3675-3678.
15. Yamashita M, Krystal M, Fitch WM, Palese P, (1988) Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology 163: 112-122.
16. Matsuzaki Y, Sugawara K, Takashita E, Muraki Y, Hongo S, et al. (2004) Genetic diversity of influenza B virus: the frequent reassortment and cocirculation of the genetically distinct reassortant viruses in a community. J Med Virol 74: 132-140.
17. Lindstrom SE, Hiromoto Y, Nishimura H, Saito T, Nerome R, et al. (1999) Comparative analysis of evolutionary mechanisms of the hemagglutinin and three internal protein genes of influenza B virus: multiple cocirculating lineages and frequent reassortment of the NP, M, and NS genes. J Virol 73: 4413-4426.
18. Tang JW, Tambyah PA, Lai FY, Lee HK, Lee CK, et al. (2010) Differing symptom patterns in early pandemic vs seasonal influenza infections. Arch Intern Med 170: 861-867.
19. Kaji M, Watanabe A, Aizawa H, (2003) Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology 8: 231-233.
20. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935-1944.
21. Patel M, Dennis A, Flutter C, Khan Z, (2010) Pandemic (H1N1) 2009 influenza. Br J Anaesth 104: 128-142.
22. World Health Organization (WHO) (2002) WHO Manual on Animal InfluenzaDiagnosis and Surveillance. Available: http://www.who.int/vaccine_research/diseases/influenza/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf. Accessed 2011 Oct 19.
23. Influenza FluNet. World Health Organization (WHO). Available: http://www.who.int/influenza/gisrs_laboratory/flunet/en/. Accessed 2011 Oct 19.
24. Hamelin ME, Baz M, Abed Y, Couture C, Joubert P, et al. (2010) Oseltamivir-resistant pandemic A/H1N1 virus is as virulent as its wild-type counterpart in mice and ferrets. PLoS Pathog 6: e1001015.
25. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460: 1021-1025.
26. Jakeman KJ, Tisdale M, Russell S, Leone A, Sweet C, (1994) Efficacy of 2′-deoxy-2′-fluororibosides against influenza A and B viruses in ferrets. Antimicrob Agents Chemother 38: 1864-1867.
27. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325: 484-487.
28. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325: 481-483.
29. Rowe T, Leon AJ, Crevar CJ, Carter DM, Xu L, et al. (2010) Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 401: 257-265.
30. Zhou B, Li Y, Belser JA, Pearce MB, Schmolke M, et al. (2010) NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets. Vaccine 28: 8015-8025.
31. Zitzow LA, Rowe T, Morken T, Shieh WJ, Zaki S, et al. (2002) Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J Virol 76: 4420-4429.
32. Recommendations for Influenza Vaccine Composition. World Health Organization (WHO). Available: http://www.who.int/influenza/vaccines/virus/recommendations/en/index.html. Accessed 2011 Oct 19.
33. Fraser C, Donnelly CA, Cauchemez S, Hanage WP, Van Kerkhove MD, et al. (2009) Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324: 1557-1561.
34. Guarner J, Falcon-Escobedo R, (2009) Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. Arch Med Res 40: 655-661.
35. O'Riordan S, Barton M, Yau Y, Read SE, Allen U, et al. (2010) Risk factors and outcomes among children admitted to hospital with pandemic H1N1 influenza. CMAJ 182: 39-44.
36. World Health Organization (WHO) (2010) Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Available: http://www.who.int/influenza/vaccines/virus/recommendations/201002_Recommendation.pdf. Accessed 2011 Oct 19.
37. World Health Organization (WHO) (2009) Recommended composition of influenza virus vaccines for use in the 2010 southern hemisphere influenza season. Available: http://www.who.int/influenza/vaccines/200909_Recommendation.pdf. Accessed 2011 Oct 19.
38. Rowe T, Banner D, Farooqui A, Ng DC, Kelvin AA, et al. (2010) In vivo ribavirin activity against severe pandemic H1N1 influenza A/Mexico/4108/2009. J Gen Virol 91: 2898-2906.
39. Reuman PD, Keely S, Schiff GM, (1989) Assessment of signs of influenza illness in the ferret model. J Virol Methods 24: 27-34.
40. Fang Y, Rowe T, Leon AJ, Banner D, Danesh A, et al. (2010) Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus. J Virol 84: 8369-8388.